TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Home > Dynamic Center >
Dynamic Center
Dynamic Center
  • Thailand's Miska Bay Health Group and Nine Chapters Biotechnology announced a new collaboration to bring the next generation of cancer and anti-aging therapies to Thailand
    On September 7, 2024, Thailand Miska Bay Health Group (hereinafter referred to as "Miska Bay Group") and Sichuan Jiuzhang Biological Science and Technology Co.,Ltd (hereinafter referred to as " Jiuzhang Bio") h...
    [View details]
  • Commun Biol Inhibition of Par-4 protein may induce iron death in glioblastoma cancer cells
    In a study entitled "Tumor suppressor Par-4 activates autophagy-dependent ferroptosis" published in the international journal Communications Biology on June 17, 2024, Research by scientists at NYU ABU Dhabi and...
    [View details]
  • FDA approves first IDH12 inhibitor for the treatment of Grade 2 oligodendroglioma or astrocytoma in patients 12 years of age and older who are susceptible to IDH1 or IDH2 mutations
    Servier's oral IDH1/IDH2 dual inhibitor vorasidenib (Voranigo) was approved by the U.S. Food and Drug Administration (FDA) on August 6, according to FirstWordPHARMA. It is used in children and adults 12 years o...
    [View details]
  • Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
    Rationale: Inducing cancer differentiation is a promising approach to treat cancer. Here, we identified chlorogenic acid (CA), a potential differentiation inducer, for cancer therapy, and elucidated the molecul...
    [View details]
    • Copyright 2017 Sichuan Jiuzhang Biological Science and Technology Co., Ltd
    Tel : 86-28-85121781 Address : No. 10，the Second South Keyuan Road, High-Tech District, Chengdu, Sichuan, China
    Shu ICP: 蜀ICP备09012251号-1 | Technology: 中联无限 http://www.cc01.com.cn